2933 related articles for article (PubMed ID: 18654426)
1. Nanocarriers as an emerging platform for cancer therapy.
Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology platforms and physiological challenges for cancer therapeutics.
Kim KY
Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine: nanocarriers shape up for long life.
Nishiyama N
Nat Nanotechnol; 2007 Apr; 2(4):203-4. PubMed ID: 18654260
[No Abstract] [Full Text] [Related]
4. Nanoparticle therapeutics: a personal perspective.
McNeil SE
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):264-71. PubMed ID: 20049796
[TBL] [Abstract][Full Text] [Related]
5. Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents.
Juliano RL; Alam R; Dixit V; Kang HM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):324-35. PubMed ID: 20049800
[TBL] [Abstract][Full Text] [Related]
6. Is nanotechnology ready for primetime?
Brower V
J Natl Cancer Inst; 2006 Jan; 98(1):9-11. PubMed ID: 16391365
[No Abstract] [Full Text] [Related]
7. Nanotechnological applications in medicine.
Caruthers SD; Wickline SA; Lanza GM
Curr Opin Biotechnol; 2007 Feb; 18(1):26-30. PubMed ID: 17254762
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine in cancer treatment.
Yih TC; Wei C
Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
[No Abstract] [Full Text] [Related]
9. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional nanocarriers.
Torchilin VP
Adv Drug Deliv Rev; 2006 Dec; 58(14):1532-55. PubMed ID: 17092599
[TBL] [Abstract][Full Text] [Related]
11. Advances in Nanocarriers for Anticancer Drugs Delivery.
Ali I; Lone MN; Suhail M; Mukhtar SD; Asnin L
Curr Med Chem; 2016; 23(20):2159-87. PubMed ID: 27048343
[TBL] [Abstract][Full Text] [Related]
12. Polymer conjugates as anticancer nanomedicines.
Duncan R
Nat Rev Cancer; 2006 Sep; 6(9):688-701. PubMed ID: 16900224
[TBL] [Abstract][Full Text] [Related]
13. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
Taurin S; Nehoff H; Greish K
J Control Release; 2012 Dec; 164(3):265-75. PubMed ID: 22800576
[TBL] [Abstract][Full Text] [Related]
14. Polymer conjugates: nanosized medicines for treating cancer.
Vicent MJ; Duncan R
Trends Biotechnol; 2006 Jan; 24(1):39-47. PubMed ID: 16307811
[TBL] [Abstract][Full Text] [Related]
15. Delivering cancer stem cell therapies - a role for nanomedicines?
Schätzlein AG
Eur J Cancer; 2006 Jun; 42(9):1309-15. PubMed ID: 16682183
[TBL] [Abstract][Full Text] [Related]
16. Anticancer drug delivery with nanoparticles.
Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
[TBL] [Abstract][Full Text] [Related]
17. Role of nanocarrier systems in cancer nanotherapy.
Mozafari MR; Pardakhty A; Azarmi S; Jazayeri JA; Nokhodchi A; Omri A
J Liposome Res; 2009; 19(4):310-21. PubMed ID: 19863166
[TBL] [Abstract][Full Text] [Related]
18. Using nanotechnology to improve the characteristics of antineoplastic drugs: improved characteristics of nab-paclitaxel compared with solvent-based paclitaxel.
Foote M
Biotechnol Annu Rev; 2007; 13():345-57. PubMed ID: 17875482
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicine and drug delivery.
Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
[TBL] [Abstract][Full Text] [Related]
20. [Peptide aptamers and nano-carriers for cancer therapy].
Shiba K
Gan To Kagaku Ryoho; 2009 Mar; 36(3):362-5. PubMed ID: 19295259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
